About Allay Therapeutics
Allay Therapeutics is a company based in Menlo Park (United States) founded in 2017.. Allay Therapeutics has raised $146.89 million across 6 funding rounds from investors including Evonik, HHS and Temasek. Allay Therapeutics offers products and services including Localized Pain Management Technology. Allay Therapeutics operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Allay Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$146.89 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Evonik
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allay Therapeutics
Allay Therapeutics offers a comprehensive portfolio of products and services, including Localized Pain Management Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology designed to provide weeks of targeted pain relief for patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Allay Therapeutics
Allay Therapeutics has successfully raised a total of $146.89M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(15 Sep 2020)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Debt – Venture - Allay Therapeutics | Valuation |
investors |
|
| Jan, 2025 | Amount | Series D - Allay Therapeutics | Valuation |
investors |
|
| Dec, 2022 | Amount | Series D - Allay Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Allay Therapeutics
Allay Therapeutics has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Evonik, HHS and Temasek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Allay Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Allay Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Allay Therapeutics Comparisons
Competitors of Allay Therapeutics
Allay Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Pain treatment products are developed through reformulation technologies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Allay Therapeutics
Frequently Asked Questions about Allay Therapeutics
When was Allay Therapeutics founded?
Allay Therapeutics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Allay Therapeutics located?
Allay Therapeutics is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Allay Therapeutics a funded company?
Allay Therapeutics is a funded company, having raised a total of $146.89M across 6 funding rounds to date.
What does Allay Therapeutics do?
Allay Therapeutics was founded in 2017 in Menlo Park, United States, within the biotechnology sector. Drugs for post-surgical pain management are developed through a proprietary platform that integrates non-opioid analgesics with biopolymers, resulting in dissolvable candidates for site-targeted relief. The lead candidate, ATX-101, is aimed at knee rehabilitation following surgery. Additional injectables, ATX-201 and ATX-301, are created for on-demand pain control.
Who are the top competitors of Allay Therapeutics?
Allay Therapeutics's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
What products or services does Allay Therapeutics offer?
Allay Therapeutics offers Localized Pain Management Technology.
Who are Allay Therapeutics's investors?
Allay Therapeutics has 11 investors. Key investors include Evonik, HHS, Temasek, Arboretum Ventures, and NEA.